{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:17:47Z","timestamp":1791487067517,"version":"4.3.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>\n                    Cancers of the endometrium, cervix, and anus are frequently treated with radiation therapy (RT), which carries a risk for secondary malignancies. RT causes vaginal atrophy, dryness, and increased mucosal friability, predisposing to ulcers. Here, we describe \u201catypical vulvovaginal postradiation vascular lesion\u201d (AVPRVL), a benign post-RT vascular lesion that histologically mimics angiosarcoma. Fifteen cases were retrospectively identified in patients aged 44 to 77 years (median: 70\u00a0y) who presented 3 to 23 years post-RT (median: 14\u00a0y), usually with vaginal bleeding. Histologically, AVPRVL demonstrated papillary endothelial hyperplasia (Masson change), mild-to-moderate nuclear atypia, and direct juxtaposition to squamous epithelium. Atypical vessels were located in fibrin and were not distributed in the native lamina propria. MYC immunohistochemistry demonstrated only scattered, weak expression in 5 tested lesions. Fluorescence in situ hybridization was negative for\n                    <jats:italic toggle=\"yes\">MYC<\/jats:italic>\n                    amplification in 11 tested lesions. Five sequenced lesions lacked recurrent pathogenic alterations or copy number changes. Clinical follow-up was available for 11 patients (73%; median length: 3.3\u00a0y; range: 1 to 21.7\u00a0y). None developed metastases. Six patients (55%) experienced persistent or recurrent lesions, although sometimes it was not possible to distinguish true recurrence from new lesions developing in the RT field. At the most recent follow-up, 9 patients were alive with no evidence of disease, and 2 were alive with recurrent lesions. Ultimately, most lesions resolved with excision or cautery. Unlike RT-associated angiosarcoma, AVPRVL lacked\n                    <jats:italic toggle=\"yes\">MYC<\/jats:italic>\n                    amplification, showed indolent clinical behavior, and usually resolved with conservative management. Unlike cutaneous atypical postradiation vascular proliferation, AVPRVL did not show vessels distributed within native subepithelial tissue. Instead, it more closely resembled a Masson change with nuclear atypia. We conclude that AVPRVL represents a distinctive, benign, possibly reactive vascular proliferation of the vulvovaginal mucosa occurring years after pelvic RT. The distinction between AVPRVL and angiosarcoma is critical to avoid overtreatment.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002510","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:00:08Z","timestamp":1768885208000},"page":"427-434","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Atypical Vulvovaginal Postradiation Vascular Lesion"],"prefix":"10.1097","volume":"50","author":[{"given":"Alexander J.","family":"Neil","sequence":"first","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne Y.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7746-3546","authenticated-orcid":false,"given":"David J.","family":"Papke","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.M.","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"R1-20260316","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.euros.2024.02.013","article-title":"Risk of secondary malignancies after pelvic radiation: a population-based analysis","volume":"63","author":"McPartland","year":"2024","journal-title":"Eur Urol Open Sci"},{"key":"R2-20260316","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/jnci\/djm201","article-title":"Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk","volume":"99","author":"Chaturvedi","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R3-20260316","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.21037\/atm-21-1393","article-title":"Second primary malignancies associated with radiation therapy in cervical cancer patients diagnosed between 1975 and 2011: a population-based competing- risk study","volume":"9","author":"Wu","year":"2021","journal-title":"Ann Transl Med"},{"key":"R4-20260316","doi-asserted-by":"crossref","first-page":"24623","DOI":"10.1038\/s41598-024-74840-4","article-title":"Association between radiation therapy for primary endometrial cancer and risk of second primary malignancies: a retrospective cohort study","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"R5-20260316","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/ijgc-2022-003686","article-title":"Gynecological radio- induced secondary malignancy after a gynecological primary tumor: a rare entity and a challenge for oncologists","volume":"32","author":"Barcellini","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R6-20260316","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bjc.6603805","article-title":"Angiosarcoma after radiotherapy: a cohort study of 332,163 Finnish cancer patients","volume":"97","author":"Virtanen","year":"2007","journal-title":"Br J Cancer"},{"key":"R7-20260316","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/PGP.0b013e318214bd05","article-title":"Postirradiation primary vaginal angiosarcoma with widespread intra-abdominal metastasis","volume":"30","author":"Brady","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"R8-20260316","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/modpathol.2011.134","article-title":"Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases","volume":"25","author":"Mentzel","year":"2012","journal-title":"Modern Pathol"},{"key":"R9-20260316","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/gcc.20827","article-title":"Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions","volume":"50","author":"Guo","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"R10-20260316","doi-asserted-by":"crossref","first-page":"152096","DOI":"10.1016\/j.anndiagpath.2022.152096","article-title":"MYC amplification in angiosarcoma depends on etiological\/clinical subgroups \u2013 diagnostic and prognostic value","volume":"63","author":"Hogeboom-Gimeno","year":"2023","journal-title":"Ann Diagn Pathol"},{"key":"R11-20260316","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2353\/ajpath.2010.090637","article-title":"MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema","volume":"176","author":"Manner","year":"2010","journal-title":"The American J Pathol"},{"key":"R12-20260316","doi-asserted-by":"crossref","first-page":"100990","DOI":"10.1016\/j.gore.2022.100990","article-title":"Radiation-induced angiosarcoma of the vagina and vulva: case report and review of literature","volume":"41","author":"Khaled","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"R13-20260316","doi-asserted-by":"crossref","first-page":"100711","DOI":"10.1016\/j.gore.2021.100711","article-title":"Angiosarcoma of the vulva following radiation for colorectal cancer","volume":"36","author":"Meyer","year":"2021","journal-title":"Gynecol Oncol Rep"},{"key":"R14-20260316","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of oncopanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"R15-20260316","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: a Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"key":"R16-20260316","doi-asserted-by":"crossref","first-page":"e87062","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"key":"R17-20260316","doi-asserted-by":"crossref","first-page":"e2216550120","DOI":"10.1073\/pnas.2216550120","article-title":"Spectra and characteristics of somatic mutations induced by ionizing radiation in hematopoietic stem cells","volume":"120","author":"Matsuda","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-20260316","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1383-5718(01)00237-6","article-title":"Genotoxic effects of radiotherapy and chemotherapy on circulating lymphocytes in patients with Hodgkin\u2019s disease","volume":"497","author":"Bilban-Jakopin","year":"2001","journal-title":"Mutat Res"},{"key":"R19-20260316","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1038\/s41467-022-33663-5","article-title":"Common anti-cancer therapies induce somatic mutations in stem cells of healthy tissue","volume":"13","author":"Kuijk","year":"2022","journal-title":"Nat Commun"},{"key":"R20-20260316","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/his.13069","article-title":"Radiation-associated neoplasia: clinical, pathological and genomic correlates","volume":"70","author":"Sholl","year":"2017","journal-title":"Histopathology"},{"key":"R21-20260316","first-page":"249","article-title":"The irradiated vagina","volume":"44","author":"Abitbol","year":"1974","journal-title":"Obstet Gynecol (New York 1953)"},{"key":"R22-20260316","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.2147\/OTT.S317160","article-title":"Intravascular papillary endothelial hyperplasia mimicking vaginal malignant tumor in a post-radiotherapy patient: a case report and literature review","volume":"14","author":"Gong","year":"2021","journal-title":"Onco Targets Ther"},{"key":"R23-20260316","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejogrb.2013.03.034","article-title":"Intravascular papillary endothelial hyperplasia (Masson\u2019s tumour) in the vulva","volume":"169","author":"Kim","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R24-20260316","doi-asserted-by":"crossref","first-page":"13030\/qt0ss9x4vf","DOI":"10.5070\/D3225030943","article-title":"Intravascular papillary endothelial hyperplasia of the vulva: report of a patient with Masson tumor of the vulva and literature review","volume":"22","author":"Beutler","year":"2016","journal-title":"Dermatol Online J"},{"key":"R25-20260316","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/LGT.0b013e3181a51a3d","article-title":"Intravascular papillary endothelial hyperplasia (Masson Tumor) manifesting as a cystic vulvar lesion","volume":"13","author":"Maghari","year":"2009","journal-title":"J Lower Genital Tract Dis"},{"key":"R26-20260316","doi-asserted-by":"crossref","first-page":"e00250","DOI":"10.1016\/j.crwh.2020.e00250","article-title":"Vulvar intravascular papillary endothelial hyperplasia or Masson\u2019s tumor: a case report","volume":"28","author":"Nwokolo","year":"2020","journal-title":"Case Rep Womens Health"},{"key":"R27-20260316","first-page":"1","article-title":"Masson\u2019s tumour of the vagina","volume":"13","author":"William","year":"2024","journal-title":"EC Gynaecology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002510","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T05:00:12Z","timestamp":1773637212000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002510"}},"subtitle":["A Distinctive, Benign Mimic of Angiosarcoma Characterized in a Series of 15 Patients"],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002510","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]}}}